37 results about "Metered Dose Nasal Spray" patented technology

The invention provides novel pharmaceutical compositions comprising the active ingredient propofol. Preferably, propofol is dissolved in at least one semifluorinated alkane. The compositions, which are preferably liquid or gel-like, may optionally comprise further excipients. They may be used as fill material in capsules, as buccal or nasal sprays, or as aerosols for pulmonary administration. They are particularly useful for the transmucosal administration of propofol.

The present invention is nasal spray of setron medicine includes the medicine component selected from Ondansetron, tropisetron and granisetron, osmotic pressure regulator and water.

A method of contraception in mammalian females, which method comprises the parenteral or rectal administration of an estrogenic component and a progestogenic component to a female of childbearing capability in an amount effective to inhibit ovulation, wherein the estrogenic component is selected from the group consisting of substances represented by the following formula (1)

in which R₁, R₂, R₃, R₄ independently are a hydrogen atom, a hydroxyl group or an alkoxy group with 1-5 carbon atoms; each of R₅, R₆, R₇ is a hydroxyl group; and no more than 3 of R₁, R₂, R₃, R₄ are hydrogen atoms; precursors capable of liberating a substance according to the aforementioned formula when used in the present method; and mixtures of one or more of the aforementioned substances and/or precursors. Another aspect of the invention concerns a drug delivery system for parenteral or rectal administration that contains the aforementioned estrogenic component and a progestogenic component, said drug delivery system being selected from the group consisting of suppositories, systems for intravaginal delivery, inhalers, nasal sprays and transdermal delivery systems.

The invention belongs to the field of medicinal preparations and relates to a nose temperature-sensitive type hydrogel spray which is prepared by dissolving a nasal decongestant, an anti-allergic rhinitis drug, a temperature-sensitive type material of poloxamer and a low viscosity bioadhesive material without mucosal toxicity into water. A gel preparation is prepared from gel temperature, the viscosity of the preparation in use is considered simultaneously, the temperature sensibility and sprayable performance of the preparation are ensured, then the preparation doses in a liquid spray manner at the room temperature (25 DEG C), the preparation is translated into semisolid gel with suitable intensity after being contacted with nasal mucosa surface, and the preparation is delayed on the nasal mucosa surface for a long time with the mucosa adhesion action of the bioadhesive. By utilizing the nose temperature-sensitive type hydrogel spray, patient medication is convenient. Compared with a common nasal cavity spray, by utilizing the nose temperature-sensitive type hydrogel spray, the residence time of the drug in a nose cavity can be prolonged so as to increase local absorption of the drug and prolong the pesticide effect.

The invention provides a Xingnaojing nasal spray and a preparation method thereof. The Xingnaojing nasal spray is prepared by taking musk, radix curcumae, cape jasmine and borneol as raw materials, and compounding above traditional Chinese medicinal herbs according to self characteristics of the traditional Chinese medicinal herbs. Through implementation of the Xingnaojing nasal spray, the incidence of die of illness and invalidism can be reduced, the disease healing effect can be improved, the course of treatment can be shortened, the prognosis can be improved, the recurrence can be prevented, and the swallowing function can be improved; and the Xingnaojing nasal spray has a relatively good therapeutic prospect.

The invention relates to a traditional Chinese medicine sharpening-mind and inducing-consciousness microemulsion nasal cavity spraying agent and a preparation method thereof. The traditional Chinese medicine sharpening-mind and inducing-consciousness microemulsion nasal cavity spraying agent comprises 10 to 20 parts of artificial musk, 2 to 8 parts of borneol, 30 to 40 parts of turmeric, 40 to 50 parts of gardenia, 10 to 20 parts of polyoxyethylene-9-laurel ether, 5 to 8 parts of sulfo-lauryl alcohol, 1 to 6 parts of yolk phospholipid, 1 to 4 parts of lecithin, 2 to 10 parts of bean phospholipid, 2 to 4 parts of vitamin E, 10 to 30 parts of refined soybean oil, 10 to 20 parts of 1,2-propylene glycol, 10 to 15 parts of glycerol, 2 to 4 parts of cholic acid, a right amount of ethanol, a right amount of purified water, a right amount of essence and a right amount of propellant. The traditional Chinese medicine sharpening-mind and inducing-consciousness microemulsion nasal cavity spraying agent has the functions of clearing away heat and toxic material, removing heat from the blood, cooling blood, promoting blood circulation, sharpening mind and inducing consciousness, is natural, innoxious, safe, effective and biodegradable, is clinically used for treating various cerebrovascular diseases and is especially effective to central coma diseases, such as disturbance of consciousness, serious symptom craniocerebral injury, cerebral hemorrhage, cerebral infarction, drug poisoning, and the like; and the medicine realizes cerebral targeting administration by the approach of a nose, can break through blood-brain barriers, can rapidly exert actions and also has convenient administration.

The present invention relates to a medicine composition for curing impotence. Said medicine composition includes edenaphy. Said medicine composition can be made into various dosage forms of tablet, capsule, powder, granules and solution, etc.

The invention discloses a naloxone hydrochloride spraying agent for oral or nasal cavity, which is prepared by naloxone hydrochloride, naloxone free alkali or the other naloxone acceptable in medicine having a ratio by weight of 1:2.5~10 with pharmaceutic edjuvant based on general spraying agent preparation process. Active ingredient of the naloxone hydrochloride spraying agent for oral or nasal cavity in the invention can directly participate intracorporeal circulation after absorbed by capillary tube under oral or nasal mucosa of a patient, thus has advantages of fast absorption and high bioavailability, without stimulating to the oral or nasal mucosa. In particular, the drugs of the invention can be taken with no requirement of use situation, so that it is convenient for using which dosage is controllable and has little side effect.

The invention belongs to the medical field, and in particular, relates to a nasal cavity spraying agent and a preparation method thereof, and a biological barrier film. The nasal spraying agent provided by the invention includes cellulose, a moisturizing agent and a solvent; the cellulose includes hydroxypropyl methyl cellulose with the type of E4M and/or hydroxyethyl methyl cellulose with the type of 20WR, and the content of the cellulose in the nasal cavity spraying agent is 9-13 g/L; the moisturizing agent includes one or more of glycerol, propylene glycol and sorbitol, and the content of the moisturizing agent in the nasal cavity spraying agent is 70-130 g/L. After the nasal cavity spraying agent is sprayed into a nasal cavity, the nasal cavity spraying agent can be evenly distributed in the nasal cavity and rapidly forms a film, and a formed film is uniform and has good barrier effect on most allergens. Experimental results show that the biological barrier film formed by the nasal cavity spraying agent provided by the invention can effectively block most allergens with the particle size of PM 2.5 or more.

The invention discloses a bepotastine besilate nasal spray and a preparation method thereof. For the nasal spray, 1-10 g of bepotastine besilate and 3-15 g of solubilizing composition are added in 100 mL of water; the solubilizing composition comprises components in percentage by weight as follows: 80%-95% of propylene glycol, polyethylene glycol 300 or polyethylene glycol 400 and the balance of caprylocaproyl macrogolglycerides; and pH of a nasal spray solution ranges from 6 to 8. In the composition, bepotastine besilate does not exist in a solid particle mode and cannot be crystallized during a long-term storage process, so that not only is rapid medicine absorption facilitated, but also a spray pump port is not blocked easily, and anaphylactic rhinitis and mucous membrane inflammation related to rhinitis can be cured effectively.

The present invention is one kind of nasal liquid medicine for treating headache and its preparation process. The medicine consists of volatile dahurian angelica oil and volatile Chuanxiong oil as the effective medicine components and pharmaceutically acceptable supplementary material. The medicine is prepared into emulsion form or gel form, such as nasal drop, nasal spray, aerosol, nasal inhalant, etc. The volatile oil as the effective component is preferably extracted through supercritical CO2 circular extraction and separation. The medicine for treating headache has high bioavailability and excellent effect.

The invention provides a nasal spray which is composed of, by weight, 8-10 parts of small centipeda herb, 6-7 parts of flos magnolia, 12-15 parts of menthol, 34-51 parts of seawater, 5-7 parts of plant cellulose, 1-2 parts of isoosmotic adjusting agent, 1-2 parts of scutellaria baicalensis, 6-8 parts of sophora flavescens, 5-8 parts of mint and 5-7 parts of agastache rugosus. Compared with the prior art, the nasal spray has the advantages that the small centipeda herb can treat nasal obstruction and nasosinusitis, menthol is used as a stimulant pharmaceutically, acts on skin or mucosa and has effects of cooling and stopping itching, can treat acute and chronic rhinitis, allergic rhinitis, hypertrophic rhinitis, nasosinusitis and paranasal sinusitis, and other medicinal excipients are added, so that the nasal spray is protruding in treatment effect, high in healing rate, simple, convenient, cheap and easy to clinically popularize.

The invention belongs to the field of pharmaceutical manufacturing, and relates to a basic fibroblast growth factor nasal spray for treating the Alzheimer's disease. The nasal spray comprises basic fibroblast growth factors, sorbefacients, stabilizers, bioadhesion agents and other pharmaceutically effective auxiliary materials. Experiment results show that the nasal spray can remarkably increase the in-brain amount of the basic fibroblast growth factors, improve the treatment effect on the Alzheimer's disease, reduce the peripheral toxic or side effects of the drugs, and be used as the new basic fibroblast growth factor preparation for treating the Alzheimer's disease.

The invention relates to a nose cavity spraying agent for curing headache and migraine and its manufacutirng method. The prescription includes medicine effective ingredients and accessories, the effective ingredients of the medicine is made up of 1-10 shares of chuanxiong rhizome extract, asarum extract and mint extract, the extraction of the effective ingredient may be steam distilling extract method or supercritical fluid extraction method, then the accessories are dissolved in the solution waterless alcohol, then adds in the effective ingredients of each medicine, they are blended fully and poured into the nose cavity spraying pump, the nose cavity spraying agent uses the rich mucous and vessels in the nose cavity, the absorption of the medicine is quick, the biology utilization rate is high, the effect is prominent, and it has no propellant, it does not use pressure resisting container, the atomization drop is tiny, it is even in the nose cavity.

There is provided non-aqueous liquid spray compositions comprising a pharmacologically acceptable non aqueous liquid carrier in which said bioactive material is directly insoluble, a pharmacologically acceptable water insoluble ester of a water soluble acid soluble in said carrier, a pharmacologically acceptable water soluble glycol soluble in said ester and a pharmacologically acceptable water soluble bio-active material soluble in said glycol but not directly soluble in the carrier. There are also provided methods of producing and administering such compositions.

The invention discloses a traditional Chinese medicine preparation for curing migraine, which is prepared by extracting 1 proportion of rhizoma ligustici wallichi, 0.45-1.2 proportions of cinnamomum migao H.W.Li, 0.40-1.1 proportions of raphani, 0.005-0.15 proportion of artificial musk, 0.002-0.03 proportion of borneol and additives, in addition, nasal cavity spraying agents and nose drops can also be prepared. According to the traditional Chinese theory of 'the brain is linked with the nose', the medicine is taken through the nasal cavity, which has rapid pain relieving effect, high potency and no toxicity and side effects.

The invention relates to a nasal spray or aerosol containing Fasudil. The active component in the preparation can be absorbed rapidly through the nasal mucosa so that the response is rapid. The nasal spray or aerosol has the advantages of high bioavailability and good compliance, and is convenient in use and carrying. The preparation provided by the invention contains Fasudil hydrochloride and pharmaceutically acceptable excipients.

The invention discloses the usage of the compound in a structural formula I in preparing drugs preventing and / or treating lung fibrosis of mammalian. The drugs can be made into orally-taken administration formulation selected from tablet, capsule, powder, granule, crystal, solution, suspension, decoction, syrup, elixirs, tea and masticatory spasm and also can be made into inhale administration or insufflation administration, intranasal administration and transdermal administration or administration formulation selected from spray of nasal cavity, nasal drop, suspension, gel, ointment, cream, emulsion and powder.

A multiple dose Naloxone spray dosage form provides a container having two or more unit doses of Naloxone or a salt thereof in a liquid that is delivered by a metered dosage spray pump. In different embodiments, ten or more, 3-500, and 10-500 unit doses are provided in the container. The metered dosage spray pump delivers 50 to about 200 μL of Naloxone solution per spray, preferably, 100 μL per spray. Each unit dose contains about 0.5 mg to 12 mg of Naloxone or a pharmaceutically acceptable salt thereof, preferably, about 2 mg to 4 mg thereof in the delivered spray. A stable pharmaceutically acceptable composition of Naloxone is used in the multiple dose Naloxone spray dosage form. A method of treatment of opioid overdose involves administration of multiple doses using the multiple dose Naloxone spray dosage form.